Thanks for having a look at Biogears.
(edit) Please have a look at: "Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344801/
https://github.com/katemeeson/repository_to_accompany_paper_...
Most successful pre-clinical trials *fail* at predicting phase III success. The ratio is enormous. It's time to put some effort into alternative approaches.
Thanks for having a look at Biogears.
(edit) Please have a look at: "Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer"
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344801/
https://github.com/katemeeson/repository_to_accompany_paper_...
Most successful pre-clinical trials *fail* at predicting phase III success. The ratio is enormous. It's time to put some effort into alternative approaches.